Frankenthal Regional Court - Trial due to possible vaccine damage begins
A woman's lawsuit for alleged health damage caused by a corona vaccination will be heard on Tuesday (10.00 a.m.) at the regional court in Frankenthal (Palatinate). According to the court, the woman from Rhineland-Palatinate is basing her lawsuit against the Mainz-based vaccine manufacturer Biontech on the fact that a second vaccination led to a bilateral pulmonary artery embolism - i.e. a blockage of blood vessels in the lungs.
Since the cause could not be determined, the woman attributed it to the vaccination. The plaintiff is claiming damages and compensation for pain and suffering. Biontech considers the claim to be unfounded. The court has ordered the appearance of the plaintiff and a representative of the defendant authorized to conclude a possible settlement. Further dates have not yet been set, but are possible.
The trial was originally scheduled for October 10, but had to be postponed due to the illness of a party to the proceedings. This is not the first trial of this kind in Germany; several lawsuits have already been dismissed due to alleged vaccination damage.
Press release
Read also:
- A clan member is punished here
- Traffic lawyer warns: Don't talk to the police!
- Will he be convicted as Jutta's murderer after 37 years?
- He also wanted to kill his cousin
- Despite several dismissed lawsuits due to alleged vaccination damage in Germany, a woman from Rhineland-Palatinate is pursuing a lawsuit against the pharmaceutical company Biontech in Mainz for health damage she claims was caused by a corona vaccination.
- The trial for the alleged vaccine damage caused by the woman's second corona vaccination begins on Tuesday at the regional court in Frankenthal (Palatinate).
- The woman's lawsuit against Biontech argues that a bilateral pulmonary artery embolism, or blockage of blood vessels in the lungs, was caused by the second vaccination, although the cause could not be determined.
- The regional court in Frankenthal has ordered the plaintiff and a representative from Biontech to appear for a possible settlement process due to the claim for damages and compensation for pain and suffering.
- Biontech considers the claim to be unfounded, and the trial is not the first of its kind in Germany, with several lawsuits already dismissed due to alleged vaccination damage.
- The trial was originally scheduled for October 10, but had to be postponed due to the illness of a party to the proceedings.
- Although there are several ongoing processes concerning vaccine damage in the Rheinland-Palatinate, the Frankenthal Regional Court will heavily focus on this particular case in Mainz.
- The trial's outcome may influence the public's perception of the pharmaceutical industry and the Covid-19 vaccination in Germany, as the Corona virus continues to spread and vaccine damage remains a controversial topic.
Source: www.stern.de
